617 filings
Page 15 of 31
8-K
vxgqisn46tmcbl8v
20 Apr 18
VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-VacĀ® Hepatitis B Vaccine
12:00am
8-K
j1tyo5etav
17 Apr 18
VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients
12:00am
DEFA14A
yzt9ckvmfb5w v9ra5q3
16 Apr 18
Additional proxy soliciting materials
12:00am
DEFA14A
xmabil6r7uhthzrx
10 Apr 18
Additional proxy soliciting materials
12:00am
8-K
m2rb nmceu6ultt
14 Mar 18
Regulation FD Disclosure
12:00am
8-K
ysjaa
12 Mar 18
VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange
12:00am
8-K
cykjiw4v tgksw6
23 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
6pvripa2 i8mfr
29 Jan 18
VBI Vaccines Announces Changes to its Board of Directors
12:00am
8-K
pidr4iq2xdxthy 50z
17 Jan 18
VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a
12:00am
8-K
osm ngy5vdp3n
19 Dec 17
Other Events
12:00am
8-K
p8irb8z hl
12 Dec 17
VBI Vaccines to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
12:00am
8-K
ptie3tp zpaxc7kr
28 Nov 17
Regulation FD Disclosure
12:00am
8-K
eqw cyllqguv
2 Nov 17
VBI Vaccines Strengthens Board of Directors with Appointment of Ran Nussbaum
12:00am
8-K
rh0ju
31 Oct 17
Entry into a Material Definitive Agreement
12:00am
424B5
5ahl1f0e
27 Oct 17
Prospectus supplement for primary offering
12:00am